Role of Dashang Guggulu and Shatpuspha Churna in PCOD in Corporate Sector Wome
- Conditions
- Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhereHealth Condition 2: N948- Other specified conditions associated with female genital organs and menstrual cycleHealth Condition 3: N948- Other specified conditions associated with female genital organs and menstrual cycle
- Registration Number
- CTRI/2023/08/055990
- Lead Sponsor
- ational Institute of Ayurveda(Deemed to be Novo),Jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Female patients of age group between 21 to 40 years (Both married and unmarried)
Patient having two out of three criteria- ASRM/ESHRE (Rotterdam) Criteria,2018
Oligo and /or anovulation
Hyperandrogenism (clinical and /or biochemical).
Polycystic ovaries (Confirmed on USG)
BMI >=23
? Patient having any other disease causing oligomenorrhoea and anovulation excluding PCOD on above criteria.
? Any organic lesions of reproductive tract like T.B., carcinoma and congenital deformities or any other pelvic pathology.
? Patient suffering from hyperprolactinemia, adrenal hyperplasia, severe insulin resistance, androgen secreting neoplasm, thyroid abnormalities, Cushingâ??s syndrome, cardiac diseases will exclude.
? Current or previous (within last 3 months) use of OC pills, Glucocorticoids, anti-androgens, ovulation induction agents, anti-diabetic, anti-obesity drugs, or other hormonal drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method